Skip to content

TPE in Rennes Hospital

Tolerance of Therapeutic Plasma Exchange Performed in the Rennes University Hospital 2011-2018

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03888417
Acronym
COMPLASMA
Enrollment
190
Registered
2019-03-25
Start date
2018-08-15
Completion date
2018-09-30
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Therapeutic Plasma Exchange

Keywords

TPE, therapeutic plasma exchange, Side Effects

Brief summary

To assess the indications, tolerance and side effects of therapeutic plasma exchange (TPE) performed at a University Hospital over 8 years

Detailed description

Indications were recorded from the patients electronic chart. Side effects were identified from the review of TPE monitoring forms completed prospectively by the nurse who performed the TPE during the course of the procedure

Interventions

All TPEs were performed by the centrifugation technique using the Fresenius Kabi COMTEC machine

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* All adult patients who underwent TPE in Rennes University Hospital 2011-2018

Exclusion criteria

* Absence of the monitoring sheet during the EP session * Refusal of patient participation after receipt of the information letter * Persons over the age of majority who are subject to legal protection (protection of justice, guardianship, guardianship)

Design outcomes

Primary

MeasureTime frameDescription
Frequency of side effects during Therapeutic plasma exchangeThe inclusion day (retrospective study)Occurrence of side effects, regardless of their severity during therapeutic plasma exchange sessions (From start of care by the nurse including the preparation for the insertion of peripheral or central venous access to disconnection from the device and removal of peripheral lines or closing the CVC),. Main side effects recorded are hypotension, tachycardia, shock, anaphylaxis, seizure, cardiac arrest, respiratory failure, skin rash, urticaria, catheter dysfunction, catheter related infection hypocalcemia, alkalosis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026